Kennedy Jr. to Permit Widespread Use of Unapproved Peptide Injections
The US Health Secretary plans to allow compounding pharmacies to prepare six peptides not yet approved by the FDA.
Robert F Kennedy Jr, serving as the US Health Secretary, has announced a significant change in policy that will permit compounding pharmacies to prepare six peptides that have not yet received approval from the Food and Drug Administration (FDA). This move aims to cater to the growing demand for these substances in the wellness market, where they have gained popularity through the influence of online personalities and marketers.
The draft plan was published in the US Federal Register on Wednesday, signaling the start of a new era for peptide use in the United States. Kennedy emphasized that the policy would advance patient choice and freedom, while also ensuring their safety. According to several outlets, the Department of Health and Human Services (HHS) does not intend to penalize pharmacies or physicians who compound these peptides, provided they adhere to certain conditions.
Under the new policy, pharmacies must conduct quality testing and submit safety reports. Additionally, the policy mandates that the ingredients used in the peptides be made by FDA-registered manufacturers and that the raw materials come with laboratory certificates. These measures aim to ensure that the peptides meet safety standards even without full FDA approval.
Kennedy’s decision comes at a time when peptides, which are short chains of amino acids acting as messengers in the body, have surged in popularity. Their use has been driven largely by the endorsement of online influencers and the promise of various health benefits. The policy will remain in effect until the FDA finalizes its own rule concerning compounded peptides, providing a temporary solution to the current regulatory gap.
What we know
- Robert F Kennedy Jr is the US Health Secretary 123
- Kennedy plans to allow compounding pharmacies to prepare six peptides not approved by the FDA 13
- The draft plan was released in the US Federal Register on Wednesday 1
- Kennedy stated that the policy advances patient choice and freedom while ensuring safety 3
- Pharmacies must conduct quality testing and safety reporting under the new policy 3
- The policy requires FDA-registered ingredient makers and lab certificates for raw ingredients 3
- Serious side effect reports are required under the new policy 3
- The policy will stay in place until the FDA finalizes a rule regarding compounded peptides 3
Powered by Quantum Forge Robotics with Jessi AI Intelligence
Verification report
- confirmed
Robert F Kennedy Jr is the US Health Secretary.
94% · supported by 3 - confirmed
Kennedy plans to allow compounding pharmacies to prepare six peptides that have not been approved by the FDA.
87% · supported by 2 - likely
Unregulated peptides have become popular in the wellness market due to marketing by online influencers.
73% · supported by 1 - likely
The draft plan was released in the US Federal Register on Wednesday.
73% · supported by 1 - likely
Kennedy stated that the policy advances patient choice and freedom while ensuring patient safety.
71% · supported by 1 - likely
HHS did not intend to take action against pharmacies or physicians compounding these peptides.
71% · supported by 1 - likely
Pharmacies must conduct quality testing and safety reporting under the new policy.
71% · supported by 1 - likely
The policy requires FDA-registered ingredient makers and lab certificates for raw ingredients.
71% · supported by 1 - likely
Serious side effect reports are required under the new policy.
71% · supported by 1 - likely
The policy will stay in place until the FDA finalizes a rule regarding compounded peptides.
71% · supported by 1 - unverified
The six peptides mentioned in the plan are BPC-157, TB-500, KPV, MOTS-c, and Semax.
53% · supported by 1, contradicted by 1 - unverified
There will be a two-week public comment period after the plan's official publication.
53% · supported by 1, contradicted by 1 - unverified
The six peptides mentioned in the policy are BPC-157, Epitalon, KPV, MOTS-c, Semax, and TB-500.
47% · supported by 1, contradicted by 1 - unverified
The policy will be open to public comment from Friday through November 13.
47% · supported by 1, contradicted by 1 - likely
Peptides are short chains of amino acids that act as messengers in the body.
73% · supported by 1
Sources & references
- BBC US & Canada — US Health Secretary RFK Jr to expand access to unapproved peptides
- NYT Business — RFK Jr. to Allow Broad Use of Unapproved Peptide Injections
- CBS News U.S. — RFK Jr. to ease access to unapproved peptides, draft policy states
